These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 28431002

  • 21. Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature.
    Rodríguez-Mañero M, Kreidieh B, Al Rifai M, Ibarra-Cortez S, Schurmann P, Álvarez PA, Fernández-López XA, García-Seara J, Martínez-Sande L, González-Juanatey JR, Valderrábano M.
    JACC Clin Electrophysiol; 2017 Mar; 3(3):253-265. PubMed ID: 29759520
    [Abstract] [Full Text] [Related]

  • 22. Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine.
    Bohora S, Lokhandwala Y, Parekh P, Vasavda A.
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):340-2. PubMed ID: 20653812
    [Abstract] [Full Text] [Related]

  • 23. [A heart without overspeed trip unit].
    Gähwiler R, Templin C, Lüscher TF, Ghadri JR.
    Praxis (Bern 1994); 2014 Apr 23; 103(9):527-31. PubMed ID: 24755501
    [Abstract] [Full Text] [Related]

  • 24. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
    Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P.
    Clin Res Cardiol; 2022 Feb 23; 111(2):141-153. PubMed ID: 32572551
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK.
    Europace; 2013 Jan 23; 15(1):116-21. PubMed ID: 22772053
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope.
    Sutton R, Salukhe TV, Franzen-McManus AC, Collins A, Lim PB, Francis DP.
    Europace; 2014 Feb 23; 16(2):284-8. PubMed ID: 24072450
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation.
    Henmi H, Imamura T.
    Intern Med; 2023 Mar 01; 62(5):813. PubMed ID: 35871598
    [No Abstract] [Full Text] [Related]

  • 31. Update on ivabradine for heart failure.
    Borer JS, Tavazzi L.
    Trends Cardiovasc Med; 2016 Jul 01; 26(5):444-9. PubMed ID: 26934996
    [Abstract] [Full Text] [Related]

  • 32. Management of inappropriate sinus tachycardia with ivabradine in a renal transplant recipient.
    Kumar Goyal V, Godara S, Chandra Sadasukhi T, Lal Gupta H.
    Drug Discov Ther; 2014 Jun 01; 8(3):132-3. PubMed ID: 25031045
    [Abstract] [Full Text] [Related]

  • 33. Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report.
    Schulze V, Steiner S, Hennersdorf M, Strauer BE.
    Cardiology; 2008 Jun 01; 110(3):206-8. PubMed ID: 18057886
    [Abstract] [Full Text] [Related]

  • 34. P-Wave Amplitude and PR Changes in Patients With Inappropriate Sinus Tachycardia: Findings Supportive of a Central Mechanism.
    Field ME, Donateo P, Bottoni N, Iori M, Brignole M, Kipp RT, Kopp DE, Leal MA, Eckhardt LL, Wright JM, Walsh KE, Page RL, Hamdan MH.
    J Am Heart Assoc; 2018 Apr 19; 7(9):. PubMed ID: 29674334
    [Abstract] [Full Text] [Related]

  • 35. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Apr 19; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 36. Intracardiac echocardiography guided anatomical ablation of the arcuate ridge for drug refractory inappropriate sinus tachycardia.
    Cabrera JS, Tapias C, Adams C, Hernandez B, Bautista W, Stozitzky V, Restrepo AJ, Saenz L.
    J Cardiovasc Electrophysiol; 2024 Jul 19; 35(7):1393-1400. PubMed ID: 38741382
    [Abstract] [Full Text] [Related]

  • 37. Modification and ablation for inappropriate sinus tachycardia: current status.
    Shen WK.
    Card Electrophysiol Rev; 2002 Dec 19; 6(4):349-55. PubMed ID: 12438812
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia.
    Calò L, Rebecchi M, Sette A, Martino A, de Ruvo E, Sciarra L, De Luca L, Zuccaro LM, Giunta G, Ciccaglioni A, Lioy E, Fedele F.
    Heart Rhythm; 2010 Sep 19; 7(9):1318-23. PubMed ID: 20621618
    [Abstract] [Full Text] [Related]

  • 39. Sinus tachycardia: don't blame the whistle-blower.
    De Pauw M, Tromp F, De Buyzere M.
    Acta Cardiol; 2013 Jun 19; 68(3):315-7. PubMed ID: 23882878
    [Abstract] [Full Text] [Related]

  • 40. Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies.
    Mathew ST, Po SS, Thadani U.
    Heart Rhythm; 2018 Feb 19; 15(2):240-247. PubMed ID: 29017929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.